2049-9361

Therapeutic Advances in Infectious Disease

SAGE Publications

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 87 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact87 DOIs
2

Add abstracts to 68 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact68 DOIs
3

Deposit reference lists for 12 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact12 DOIs

DOIs for this ISSN

Showing the top 5 of 619 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Carbapenem resistance: overview of the problem and future pe… (10.1177/2049936115621709)
ORCID
63.00 330
2 The role of nanotechnology in the treatment of viral infecti… (10.1177/2049936117713593)
ORCID
56.74 185
3 Recent advances in the understanding of antibiotic resistanc… (10.1177/2049936115622891)
ORCID
54.76 154
4 The global problem of childhood diarrhoeal diseases: emergin… (10.1177/2049936117744429)
ORCID
51.98 119
5 Extrahepatic manifestations of chronic hepatitis C virus inf… (10.1177/2049936115585942)
ORCID
50.43 103
6 <i>Blastocystis</i> , an unrecognized pa… (10.1177/2049936113504754)
ORCID
50.22 101
7 Extrapulmonary tuberculosis: are statistical reports accurat… (10.1177/2049936114528173)
ORCID
45.81 67
8 RETRACTED: Serum amyloid A protein in the course of infectio… (10.1177/2049936118811208)
Abstract References ORCID
45.15 3
9 Corrigendum to Gram negative bacteria related urinary tract… (10.1177/20499361241234513)
Abstract References ORCID
45.15 3
10 The role of the healthcare environment in the spread of mult… (10.1177/2049936114543287)
ORCID
44.63 60
11 Recent developments and future prospects in the treatment of… (10.1177/2049936116646063)
ORCID
44.63 60
12 Hepatitis E: an underestimated emerging threat (10.1177/2049936119837162)
ORCID
43.70 55
13 Management of community-acquired pneumonia in older adults (10.1177/2049936113518041)
ORCID
42.47 49
14 Dengue fever-induced cold-agglutinin syndrome (10.1177/2049936114559918)
Abstract ORCID
42.25 6
15 Azithromycin, cardiovascular risks, QTc interval prolongatio… (10.1177/2049936113501816)
ORCID
41.80 46
16 The host immune response to <i>Clostridi… (10.1177/2049936112472173)
ORCID
39.21 36
17 Best practice in the prevention and management of paediatric… (10.1177/2049936116630243)
ORCID
39.21 36
18 Success of antimicrobial stewardship programmes – it starts… (10.1177/20499361221139594)
Abstract ORCID
38.91 5
19 Management of acute bacterial skin and skin structure infect… (10.1177/2049936117723228)
ORCID
38.29 33
20 Invasive fungal infections in transplant recipients (10.1177/2049936113491936)
ORCID
37.63 31
21 Clinical management of infections caused by multidrug-resist… (10.1177/2049936113476284)
ORCID
37.28 30
22 Risk factors and outcomes for multidrug-resistant Gram-negat… (10.1177/2049936117727497)
ORCID
34.51 23
23 Bloodstream infections and antimicrobial sensitivity pattern… (10.1177/2049936116666983)
ORCID
34.04 22
24 Viral infections and the development of asthma in children (10.1177/2049936113497202)
ORCID
33.56 21
25 Management of febrile neutropenia in the era of bacterial re… (10.1177/2049936113475610)
ORCID
33.06 20
26 Telavancin: a novel semisynthetic lipoglycopeptide agent to… (10.1177/2049936117690501)
ORCID
33.06 20
27 COVID-19 associated mucormycosis: the urgent need to reconsi… (10.1177/20499361211027065)
Abstract
33.06 20
28 Urogenital tuberculosis: definition and classification (10.1177/2049936115572064)
ORCID
32.53 19
29 The implications of whole-genome sequencing in the control o… (10.1177/2049936115624630)
ORCID
32.53 19
30 Overcoming the global burden of neglected tropical diseases (10.1177/2049936120966449)
Abstract
32.53 19
31 A resurgence and re-emergence of diphtheria in Nigeria, 2023 (10.1177/20499361231161936)
Abstract
31.38 17
32 Clarithromycin, QTc interval prolongation and… (10.1177/2049936113497203)
ORCID
30.76 16
33 Erythromycin, QTc interval prolongation, and… (10.1177/2049936114527744)
ORCID
30.10 15
34 A meta-analysis of antibacterial envelope use in prevention… (10.1177/2049936117702317)
ORCID
28.65 13
35 The current status of community-acquired pneumonia managemen… (10.1177/2049936116652326)
ORCID
27.85 12
36 Current tools available for the diagnosis of drug-resistant… (10.1177/2049936116673553)
ORCID
27.85 12
37 Zoom Burnout Amidst a Pandemic: Perspective from a Medical S… (10.1177/20499361211026717)
Abstract
27.85 12
38 Relevance of liver failure for anti-infective agents: from p… (10.1177/2049936113519089)
ORCID
26.98 11
39 Treatment optimization for HIV/HCV co-infected patients (10.1177/2049936116681279)
ORCID
26.98 11
40 Visceral scalloping on abdominal computed tomography due to… (10.1177/2049936116685262)
ORCID
26.98 11
41 Antimicrobial effects of lysophosphatidylcholine on methicil… (10.1177/2049936117714920)
ORCID
26.98 11
42 A study of antibiotic prescription pattern in patients refer… (10.1177/2049936118773216)
ORCID
26.98 11
43 Recent Nipah virus outbreak in India: lessons and imperative… (10.1177/20499361231208535)
Abstract
26.98 11
44 Community-acquired pneumonia: identification and evaluation… (10.1177/2049936112469017)
ORCID
26.03 10
45 A case of testicular tuberculosis mimicking malignancy in a… (10.1177/2049936116655261)
ORCID
26.03 10
46 Oral mucositis caused by <i>Candida glab… (10.1177/2049936116684477)
ORCID
26.03 10
47 Gallbladder tuberculosis camouflaging as gallbladder cancer… (10.1177/2049936116678589)
ORCID
25.00 9
48 Examining the effectiveness of a cognitive intervention to i… (10.1177/2049936117736456)
ORCID
25.00 9
49 From presumptive exclusion towards fair inclusion: perspecti… (10.1177/20499361221075454)
Abstract
25.00 9
50 Marburg virus disease amid COVID-19 in West Africa: an emerg… (10.1177/20499361231168520)
Abstract
25.00 9